Sign in

CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
  1. DEF 14A Proxy Proxy Statement
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. PRE 14A Proxy Proxy Statement (Preliminary)
  4. 8-K Event Other events
  5. 4 Open-market buy Chief Financial Officer bought 21,000 shares at $1.23 ($25,830)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 8-K Event Shareholder vote results · Other events
  12. 8-K Event Executive or director change
  13. 8-K Event Executive or director change · Other events
  14. 8-K Event New debt or obligation · Unregistered share sale · Regulation FD disclosure
  15. 10-Q Report Quarterly Report
  16. 8-K Event Material agreement · Agreement ended · Results of operations · New debt or obligation · Unregistered share sale
  17. 8-K Event Results of operations · Other events
  18. 8-K Event Results of operations · Regulation FD disclosure · Other events
  19. DEFA14A Proxy Proxy Materials
  20. ARS Other Annual Report to Security Holders

Page 2 of 45 · 895 filings